N4 Pharma

N4P:LNLondon Stock Exchange

Overview

Company Profile

We’re N4 Pharma, a specialist pharmaceutical company developing a novel silica nanoparticle delivery system for vaccines and therapeutics for licensing to pharmaceutical and biotech partners. This nanoparticle has the potential to help commercialise cancer immunotherapy drugs and improve the effectiveness of viral vaccines.

Classification

SectorHealthcare
ExchangeLondon Stock Exchange
IndustryPharmaceuticals